JP2011521216A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011521216A5 JP2011521216A5 JP2011508900A JP2011508900A JP2011521216A5 JP 2011521216 A5 JP2011521216 A5 JP 2011521216A5 JP 2011508900 A JP2011508900 A JP 2011508900A JP 2011508900 A JP2011508900 A JP 2011508900A JP 2011521216 A5 JP2011521216 A5 JP 2011521216A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- marker
- autoantigen
- biological sample
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003550 marker Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 11
- 239000012472 biological sample Substances 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 2
- 238000003018 immunoassay Methods 0.000 claims description 2
- 101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 claims 7
- 102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 claims 7
- 230000003197 catalytic effect Effects 0.000 claims 7
- 239000012634 fragment Substances 0.000 claims 7
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 6
- 101100406797 Arabidopsis thaliana PAD4 gene Proteins 0.000 claims 3
- 101150094373 Padi4 gene Proteins 0.000 claims 3
- 102100035731 Protein-arginine deiminase type-4 Human genes 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 108010074051 C-Reactive Protein Proteins 0.000 claims 1
- 102100032752 C-reactive protein Human genes 0.000 claims 1
- 102000004889 Interleukin-6 Human genes 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 102000005482 Lipopolysaccharide Receptors Human genes 0.000 claims 1
- 108010031801 Lipopolysaccharide Receptors Proteins 0.000 claims 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims 1
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims 1
- 108010016160 Matrix Metalloproteinase 3 Proteins 0.000 claims 1
- 102000004264 Osteopontin Human genes 0.000 claims 1
- 108010081689 Osteopontin Proteins 0.000 claims 1
- 102000013674 S-100 Human genes 0.000 claims 1
- 108700021018 S100 Proteins 0.000 claims 1
- 108700028909 Serum Amyloid A Proteins 0.000 claims 1
- 102000054727 Serum Amyloid A Human genes 0.000 claims 1
- 102100030416 Stromelysin-1 Human genes 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 230000003460 anti-nuclear Effects 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 229940100601 interleukin-6 Drugs 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- -1 rheumatoid factor Proteins 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 210000001179 synovial fluid Anatomy 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 238000003556 assay Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08305167.2 | 2008-05-14 | ||
| EP08305167 | 2008-05-14 | ||
| PCT/EP2009/055731 WO2009138408A2 (en) | 2008-05-14 | 2009-05-12 | Methods and kits for the diagnosis of rheumatoid arthritis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011521216A JP2011521216A (ja) | 2011-07-21 |
| JP2011521216A5 true JP2011521216A5 (enExample) | 2014-04-03 |
| JP5663723B2 JP5663723B2 (ja) | 2015-02-04 |
Family
ID=39643997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508900A Expired - Fee Related JP5663723B2 (ja) | 2008-05-14 | 2009-05-12 | 関節リウマチの診断のための方法およびキット |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8338188B2 (enExample) |
| EP (1) | EP2286233A2 (enExample) |
| JP (1) | JP5663723B2 (enExample) |
| WO (1) | WO2009138408A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2336769A1 (en) * | 2009-12-18 | 2011-06-22 | F. Hoffmann-La Roche AG | Trigger assay for differentiating between rheumatic and non-rheumatic disorders |
| RU2603484C2 (ru) * | 2011-05-10 | 2016-11-27 | Нестек С.А. | Способы диагностирования дегенеративного поражения сустава |
| EP2527841A1 (en) | 2011-05-25 | 2012-11-28 | Toscana Biomarkers S.r.l. | Methods for the diagnosis of rheumatoid arthritis |
| EP2745115B1 (de) * | 2011-08-19 | 2016-05-18 | Protagen AG | Neues verfahren zur diagnostik von hochaffinen bindern und markersequenzen |
| EP2644704A1 (de) * | 2012-03-27 | 2013-10-02 | Protagen AG | Markersequenzen für Rheumatoide Arthritis |
| US20150293120A1 (en) | 2012-03-27 | 2015-10-15 | Protagen Ag | Marker sequences for rheumatoid arthritis |
| EP3029464A4 (en) * | 2013-07-31 | 2017-03-08 | Kyoto University | Method for assessing autoimmune arthritis, and screening method for substances inhibiting activity of autoimmune arthritis-inducing t cells |
| JP2017532042A (ja) | 2014-10-29 | 2017-11-02 | 10エックス ゲノミクス,インコーポレイテッド | 標的化核酸配列決定のための方法及び組成物 |
| EP4129278A1 (en) | 2015-07-03 | 2023-02-08 | Lars Klareskog | Methods and compounds for the alleviation and/or prevention of bone loss and/or pain |
| EP3436828A1 (de) | 2016-04-02 | 2019-02-06 | Protagen AG | Markersequenzen für rheumatoide arthritis |
| CN106950365B (zh) * | 2017-02-15 | 2018-11-27 | 中国医学科学院北京协和医院 | 一种acpa阴性的ra诊断标志物及其应用 |
| US10742435B2 (en) | 2017-06-29 | 2020-08-11 | Google Llc | Proactive provision of new content to group chat participants |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208479A (en) * | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
| CA2552420A1 (en) * | 2004-02-27 | 2005-09-15 | F. Hoffmann-La Roche Ag | Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a |
| JP4411416B2 (ja) * | 2004-11-09 | 2010-02-10 | 独立行政法人理化学研究所 | 関節リウマチ診断における抗シトルリン化コラーゲン・タイプiコラーゲンの利用 |
| WO2007123976A2 (en) * | 2006-04-18 | 2007-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Antibody profiling for determination of patient responsiveness |
-
2009
- 2009-05-12 WO PCT/EP2009/055731 patent/WO2009138408A2/en not_active Ceased
- 2009-05-12 EP EP09745740A patent/EP2286233A2/en not_active Withdrawn
- 2009-05-12 US US12/989,806 patent/US8338188B2/en not_active Expired - Fee Related
- 2009-05-12 JP JP2011508900A patent/JP5663723B2/ja not_active Expired - Fee Related
-
2012
- 2012-12-21 US US13/724,595 patent/US20130178388A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011521216A5 (enExample) | ||
| US8357495B2 (en) | Immunoassay of analytes in samples containing endogenous anti-analyte antibodies | |
| CN102725633B (zh) | 用于诊断心肌细胞损害的测定 | |
| JP5703460B2 (ja) | タンパク質含有量の測定方法 | |
| JP2010508515A (ja) | 心筋トロポニン自己抗体アッセイ | |
| JP2012522232A5 (enExample) | ||
| CA2747253A1 (en) | Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd | |
| JP6275869B2 (ja) | 関節リウマチの診断のための組成物及び方法 | |
| CN103380379B (zh) | 尿路感染的诊断方法 | |
| Manole et al. | Immunoassay techniques highlighting biomarkers in immunogenetic diseases | |
| EP2823311A1 (en) | Biomarkers for systemic lupus erythematosus | |
| WO2008035527A1 (fr) | ANTICORPS MONOCLONAL ANTI-C1q | |
| CN103091496A (zh) | 免疫测定试剂、生物传感器和检测分析物的方法 | |
| US20130217015A1 (en) | Hmga2 as a biomarker for diagnosis and prognosis of ovarian cancer | |
| KR101794403B1 (ko) | 쇼그렌증후군 특이적 항체반응 검사를 이용한 쇼그렌증후군 진단방법 | |
| Konstantinov et al. | Detection of autoantibodies in a point-of-care rheumatology setting | |
| Sharmin et al. | Association of immunofluorescence pattern of antinuclear antibody with specific autoantibodies in the Bangladeshi population | |
| JP2010091308A (ja) | レクチン吸収法による前立腺がんの診断方法及び判定キット | |
| JP7668220B2 (ja) | 関節リウマチの診断及び評価のための、組成物並びに方法 | |
| CN102346186A (zh) | 用于检测生物标本中的过氧化物还原酶ⅳ抗体的elisa试剂盒及其方法与运用 | |
| JP2022182394A (ja) | 抗原固相化デバイス | |
| JP7611275B2 (ja) | 原発性胆汁性肝硬変を診断するための組成物及び方法 | |
| Pyun et al. | Performance characteristic of anti-cyclic citrullinated peptide (CCP) assay on Korean rheumatoid arthritis (RA) patients and healthy controls | |
| CN102246044A (zh) | 体液中ifi 16的检测 | |
| Fu et al. | A modified quick PETIA for detecting anti-CCP antibodies in human serum |